Description: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.
Home Page: www.zhongxinp.com
Zhong Xin Mansion
Tianjin,
300193
China
Phone:
86 22 2702 0892
Officers
| Name | Title |
|---|---|
| Ms. Niu Shengfang | Deputy GM & Deputy Chief Accountant |
| Mr. Jian Zhang | Deputy Gen. Mang. |
| Ms. Xin Wang | Deputy Gen. Mang. |
| Ms. Lei Wang | Gen. Mang. |
| Mr. Hong Zhou | Deputy GM, Chief Engineer & Exec. Director |
| Mr. Mai Wang | Employee Director and Chairman of the Union & Director of the organization department |
| Mr. Min Guo | Exec. Director |
| Mr. Yu Zhang | Chief Production Officer |
| Ms. Yan Jiao | Sec. to the Board of Directors |
Exchange: SHG
Country: CN
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 29.2685 |
| Price-to-Book MRQ: | 3.4562 |
| Price-to-Sales TTM: | 2.5663 |
| IPO Date: | 1997-06-27 |
| Fiscal Year End: | December |
| Full Time Employees: | 4650 |